X4 Pharmaceuticals (XFOR) Inventory (2024 - 2025)
X4 Pharmaceuticals (XFOR) reported Inventory of $4.5 million for Q4 2025, up 59.0% on a YoY basis from $2.8 million in Q4 2024, and up 9.78% quarter-over-quarter from $4.1 million in Q3 2025.
X4 Pharmaceuticals (XFOR) Inventory (2024 - 2025) Analysis & Trends
X4 Pharmaceuticals has reported Inventory for 2 years, with the latest figure at $4.5 million in Q4 2025.
- For the quarter ending Q4 2025, Inventory rose 59.0% year-over-year to $4.5 million; the trailing twelve-month figure through Dec 2025 stood at $4.5 million (up 59.0% YoY), and the FY2025 full-year result was $4.5 million, up 59.0% from the prior year.
- Inventory for Q4 2025 stood at $4.5 million, up from $4.1 million in the prior quarter.
- The five-year high for Inventory was $4.5 million in Q4 2025, with the low at $831000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 32.00 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.77 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | X4 Pharmaceuticals | 156.06 Mn | 156.06 Mn | 2.20 Mn | 4.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.48 Mn |
| Sep 30, 2025 | 4.08 Mn |
| Jun 30, 2025 | 3.17 Mn |
| Mar 31, 2025 | 3.09 Mn |
| Dec 31, 2024 | 2.82 Mn |
| Sep 30, 2024 | 2.45 Mn |
| Jun 30, 2024 | 831,000.00 |